Amass Brands (AMSS) · Oct 14, 2026 · Delisting

AMASS Nasdaq warning adds $1 bid-price test to delisting risk

Nasdaq deficiency — Below $1.00 for 30 business days; cure deadline April 7, 2027

AMASS Brands received a Nasdaq deficiency notice after 30 days below $1, adding a second listing hurdle ahead of its January 2027 market-value deadline.

AMASS is a recently Nasdaq-listed, multi-category beverage company selling alcoholic and non-alcoholic brands through wholesale and online channels; it is still building scale after its May 2026 direct listing. This filing adds a second, separate Nasdaq problem. The company failed the $1 minimum bid-price rule after its stock closed below $1 for 30 consecutive business days from August 26 through October 8.

RequirementStatus / deadline
Nasdaq minimum bid priceBelow $1.00 for 30 consecutive business days
First cure periodThrough April 7, 2027
Required recoveryAt least $1.00 closing bid for 10 consecutive business days
Previously disclosed MVLS/MVPHS deficiencyCompliance deadline January 19, 2027

The immediate consequence is limited, but the capital-markets risk is materially higher. Nasdaq has not suspended or delisted the shares now, and AMASS has 180 calendar days to restore the bid price. 〔0〕 But this is not a standalone warning: the company already had separate deficiencies involving the market value of listed securities and publicly held shares, with an earlier January 19, 2027 deadline. 〔1〕

The path to preserving the listing is now more demanding than the company’s framing suggests. If AMASS cannot regain the bid-price requirement by April 7, it may seek a second 180-day period by transferring to Nasdaq’s Capital Market, but only if it satisfies that market’s other listing standards. Failure across the available periods would make the common stock subject to delisting. 〔2〕 That makes the January market-value deadline the nearer test, while the new bid-price deficiency adds another condition that could complicate future financing, liquidity, and investor access.

Bottom line: This does not change AMASS’s beverage operations today, but it meaningfully weakens the company’s listing and financing position. The market already knew AMASS had one Nasdaq deficiency; the new sub-$1 notice makes the compliance problem broader and more urgent, not routine confirmation.

What to watch next

MVLS/MVPHS compliance deadline, January 19, 2027

Original filing on SEC EDGAR

More Amass Brands news

AMASS Nasdaq warning adds $1 bid-price test to delisting risk | AMSS Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.